# Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients

> **NCT02376452** · PHASE2 · UNKNOWN · sponsor: **Fudan University** · enrollment: 100 (estimated)

## Conditions studied

- Colorectal Carcinoma

## Interventions

- **DRUG:** Raltitrexed
- **DRUG:** Irinotecan
- **DRUG:** 5-fluorouracil
- **DRUG:** Leucovorin

## Key facts

- **NCT ID:** NCT02376452
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2015-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02376452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02376452, "Phase II Study of 2-weekly RAILIRI Versus FOLFIRI as Second-line Treatment in Advanced Colorectal Cancer Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02376452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*